Table 5.

Hemodynamic variables of PH associated with patients with PA and patients with IPAH. Values are mean ± SD or n (%) unless otherwise specified.

CharacteristicsPH Due to PA, n = 12IPAH, n = 30p
Female sex, n1120NS
mPAP, mmHg51.6 ± 11.353.0 ± 18.0NS
mRAP, mmHg6.6 ± 2.65.6 ± 3.1NS
Qp/Qs ratio0.8 ± 0.31.0 ± 0.30.02
PVR, dyne/s/cm51157.1 ± 442.91204.0 ± 538.0NS
CI, l/min/m22.0 ± 0.53.0 ± 1.20.05
VO2 max, ml/kg/min11.5 ± 1.713.4 ± 2.80.04
SvO2, %57.7 ± 3.968.5 ± 8.60.01
Inhaled iloprost
  Elevated CI12 (100)12 (40.0)0.001
  Decreased PVR > 20%12 (100)10 (33.3)< 0.001
  Decreased mPAP > 20%12 (100)10 (33.3)< 0.001
  Decreased percentage of PVR, %27.1 ± 4.416.6 ± 5.8< 0.001
  Decreased percentage of mPAP, %28.7 ± 2.315.6 ± 6.60.002
  Acute vasodilator responders12 (100)10 (33.3)< 0.001
  • Only statistically significant p values are shown. PH: pulmonary hypertension; PA: pulmonary arteritis; IPAH: idiopathic pulmonary arterial hypertension; mPAP: mean pulmonary artery pressure; mRAP: mean right atrial pressure; Qp/Qs ratio: pulmonary to systemic flow; VO2 max: average peak oxygen uptake; SvO2: mixed venous oxygen saturation; PVR: pulmonary vascular resistance; NS: nonsignificant; CI: cardiac index.